Tandem Diabetes Care (TNDM) Competitors $15.59 -0.58 (-3.59%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$15.74 +0.15 (+0.96%) As of 07/11/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TNDM vs. SLNO, TMDX, INSP, NVST, PRCT, LIVN, WRBY, ENOV, NVCR, and LMATShould you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), Enovis (ENOV), NovoCure (NVCR), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Tandem Diabetes Care vs. Its Competitors Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker Enovis NovoCure LeMaitre Vascular Tandem Diabetes Care (NASDAQ:TNDM) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation. Which has higher earnings & valuation, TNDM or SLNO? Tandem Diabetes Care has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$940.20M1.10-$96.03M-$2.78-5.61Soleno TherapeuticsN/AN/A-$175.85M-$4.62-17.66 Do insiders & institutionals hold more shares of TNDM or SLNO? 97.4% of Soleno Therapeutics shares are owned by institutional investors. 1.9% of Tandem Diabetes Care shares are owned by company insiders. Comparatively, 6.4% of Soleno Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to TNDM or SLNO? In the previous week, Soleno Therapeutics had 3 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 15 mentions for Soleno Therapeutics and 12 mentions for Tandem Diabetes Care. Soleno Therapeutics' average media sentiment score of 0.92 beat Tandem Diabetes Care's score of 0.75 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 4 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate TNDM or SLNO? Tandem Diabetes Care currently has a consensus target price of $32.71, indicating a potential upside of 109.84%. Soleno Therapeutics has a consensus target price of $108.70, indicating a potential upside of 33.26%. Given Tandem Diabetes Care's higher probable upside, research analysts clearly believe Tandem Diabetes Care is more favorable than Soleno Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 1 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Which has more volatility & risk, TNDM or SLNO? Tandem Diabetes Care has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.63, indicating that its share price is 363% less volatile than the S&P 500. Is TNDM or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to Tandem Diabetes Care's net margin of -18.71%. Tandem Diabetes Care's return on equity of -57.33% beat Soleno Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-18.71% -57.33% -13.48% Soleno Therapeutics N/A -77.52%-63.44% SummaryTandem Diabetes Care and Soleno Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNDM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNDM vs. The Competition Export to ExcelMetricTandem Diabetes CareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.08B$6.90B$5.62B$9.09BDividend YieldN/A1.25%5.24%4.00%P/E Ratio-5.6126.3028.1320.27Price / Sales1.1049.05428.2698.57Price / CashN/A20.9237.4658.16Price / Book3.894.648.045.49Net Income-$96.03M$174.76M$3.18B$250.45M7 Day Performance-8.64%-1.00%3.62%4.79%1 Month Performance-25.48%-1.49%4.06%7.68%1 Year Performance-66.16%4.27%30.01%16.43% Tandem Diabetes Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNDMTandem Diabetes Care4.1295 of 5 stars$15.59-3.6%$32.71+109.8%-65.5%$1.08B$940.20M-5.612,650Positive NewsAnalyst ForecastSLNOSoleno Therapeutics4.6253 of 5 stars$85.27-1.6%$107.10+25.6%+83.3%$4.30BN/A-18.4630Trending NewsAnalyst ForecastTMDXTransMedics Group2.2237 of 5 stars$125.17-3.1%$127.33+1.7%-21.9%$4.23B$441.54M92.04210News CoveragePositive NewsAnalyst RevisionINSPInspire Medical Systems4.9095 of 5 stars$127.11-1.1%$211.91+66.7%-3.8%$3.75B$802.80M58.581,246News CoveragePositive NewsAnalyst UpgradeNVSTEnvista3.2645 of 5 stars$19.66-3.6%$20.23+2.9%+20.7%$3.33B$2.51B-3.0112,300Analyst ForecastPRCTPROCEPT BioRobotics2.3187 of 5 stars$56.97-1.6%$90.00+58.0%-17.1%$3.15B$224.50M-33.51430News CoverageAnalyst ForecastLIVNLivaNova3.1681 of 5 stars$45.58-1.2%$59.29+30.1%-15.4%$2.49B$1.25B-11.142,900Positive NewsWRBYWarby Parker2.4559 of 5 stars$21.40-3.8%$22.88+6.9%+42.1%$2.24B$795.09M-178.333,780News CoveragePositive NewsAnalyst DowngradeENOVEnovis2.6286 of 5 stars$33.03-1.8%$58.00+75.6%-25.5%$1.89B$2.15B-2.377,367Analyst ForecastNVCRNovoCure3.6691 of 5 stars$16.89-4.6%$32.83+94.4%-0.7%$1.88B$605.22M-11.191,488Analyst ForecastLMATLeMaitre Vascular2.4884 of 5 stars$82.98-1.7%$97.83+17.9%-1.6%$1.87B$219.86M41.91490News CoveragePositive News Related Companies and Tools Related Companies SLNO Alternatives TMDX Alternatives INSP Alternatives NVST Alternatives PRCT Alternatives LIVN Alternatives WRBY Alternatives ENOV Alternatives NVCR Alternatives LMAT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNDM) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredDid you miss out on Trump’s “birthday gift” to Americans?While protestors were rallying against “King Trump,” one trader quietly spotted a 15% weekend move tied to his...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
